C. Di Blasi et al., Partial laminin alpha 2 chain deficiency in a patient with myopathy resembling inclusion body myositis, ANN NEUROL, 47(6), 2000, pp. 811-816
It is becoming evident that clinical phenotypes associated with partial lam
inin alpha 2 chain deficiency are variable. We recently observed a 29-year-
old man with leukoencephalopathy and vacuolar myopathy resembling inclusion
body myositis. Laminin alpha 2 immunohistochemical analysis showed reducti
on of the protein on muscle fiber surfaces. Molecular analysis revealed two
novel compound heterozygous mutations in the LAMA2 gene. This is the first
report linking a mutation in the LAMA2 gene with leukoencephalopathy and i
nclusion body-like myositis.